分支胰管型IPMN壁结节与高级别异型增生:局部治疗安全性的再评估
该观察性研究纳入82例因分支胰管型IPMN(BD-IPMN)伴壁结节行胰腺切除的患者,旨在明确最高级别异型增生与壁结节的位置关系。结果显示45%的患者在壁结节之外存在高级别异型增生或浸润癌,仅7%的高级别异型增生局限于壁结节内,提示局部消融治疗可能不安全,支持胰腺切除作为首选方案。
要点
- BD-IPMN壁结节患者中45%在结节外存在高级别异型增生或癌,局部治疗需谨慎。
- 仅7%患者的高级别异型增生完全局限于壁结节内,多数病变范围超出结节。
- 女性及主胰管直径<5mm与「适合局部治疗」独立相关,但需进一步验证。
核心结论
- 在切除的胰腺标本中,BD-IPMN壁结节患者近半数在壁结节之外存在高级别异型增生,对局部治疗的安全性提出质疑,支持胰腺切除作为最佳方案。
研究设计与样本
- 观察性研究,纳入2012-2022年因BD-IPMN伴壁结节(术前影像确认强化壁结节) suspected high-risk IPMN而行胰腺切除的患者82例(男性44例,54%;平均年龄65±9.2岁)。
主要发现
- BD-IPMN平均大小32±14.8 mm,壁结节平均直径10.5±5.6 mm,主胰管平均直径5.2±3.6 mm。
- 6例(7%)为浸润癌,37例(45%)为高级别异型增生(HGD),39例(48%)仅为低级别异型增生。
- 壁结节存在异型增生者70例(85%);壁结节被视为局部消融相关靶点者45例(55%),而37例(45%)在壁结节之外存在HGD或浸润癌。
- HGD仅局限于壁结节内者6/82例(7%)。
- 与「适合局部治疗」独立相关的因素为女性(P=0.004;OR=5.2,95%CI 1.7-15.9)和主胰管<5 mm(P<0.0001;OR=8.6,95%CI 2.7-26.8)。
临床怎么用
- 对于BD-IPMN伴壁结节的患者,应警惕壁结节之外存在高级别异型增生或癌的可能,局部消融治疗前需充分评估。
- 当前证据支持将胰腺切除作为BD-IPMN伴壁结节患者的标准治疗选择。
局限性
- 本研究为观察性研究,样本量有限(82例),结论需更大规模研究验证。
- 仅纳入接受胰腺切除的患者,存在选择偏倚,可能高估病变严重程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A mural module (MN) within a branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) could be a potential target for local treatment. The main aim was to describe the location of the highest grade of dysplasia relative to the mural module to assess the relevance of local treatment. METHODS: Observational study of patients who underwent a pancreatic resection for suspected high-risk IPMN because of a mural module within a BD-IPMN (2012-2022). All patients had preoperative imaging confirming the enhancing mural module. The mural module was considered as a theoretical appropriate target for local destruction if no cancer or high-grade dysplasia (HGD) was described elsewhere than in the mural module. RESULTS: Eighty-two patients (male: 44 (54%); mean age: 65 ± 9.2 years) were included. The mean size of BD-IPMN containing the mural module was 32 ± 14.8 mm. The mural module mean diameter was 10.5 ± 5.6 mm, and the main pancreatic duct (MPD) mean diameter was 5.2 ± 3.6 mm. Six patients presented invasive carcinoma (7%), 37 had HGD (45%), and 39 (48%) had exclusively low-grade dysplasia. The mural module was dysplastic in 70 cases (85%). The mural module was considered a relevant target for local ablation in 45 patients (55%), whereas 37 patients (45%) had HGD/invasive carcinoma distant from the mural module. HGD was exclusively present in the mural module in 6/82 patients (7%). Factors independently associated with 'relevant indication for local treatment' were female gender (P = 0.004; OR = 5.2, 95% c.i. 1.7 to 15.9) and MPD < 5 mm (P < 0.0001; OR = 8.6, 95% c.i. 2.7 to 26.8). CONCLUSION: In resected pancreata, BD-IPMN mural modules are associated with HGD distant from the mural module almost half of cases. The findings question the safety of local treatment, supporting pancreatectomy as the best approach.
引用
- Lorenzo D, Aguilera Munoz L, Vedie AL, et al. Mural nodules and prevalence of high-grade dysplasia in branch duct intraductal papillary mucinous neoplasm of the pancreas undergoing resection. Br J Surg. 2024. PMID: 39612583. doi:10.1093/bjs/znae292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。